$RSPI RespireRx Pharmaceuticals Inc. Insider Trading
Get free email notifications about insider trading in RespireRx Pharmaceuticals Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in RespireRx Pharmaceuticals Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in RespireRx Pharmaceuticals Inc. for free.
IRS Number: 330303583
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: RSPI
Company Address: 126 VALLEY ROAD SUITE C GLEN ROCK 07452
Phone number: (201) 444-4947
Former name: X-Age, Inc.
Former name: CORTEX PHARMACEUTICALS INC/DE/, date of change: 1992-07-03
RespireRx Pharmaceuticals, Inc. engages in the discovery, development and commercialization of innovative pharmaceuticals for the treatment of neurological and psychiatric disorders. The company was founded by Carl W. Cotman, Wayne Pambianchi and Gary S. Lynch on February 10, 1987 and is headquartered in Glen Rock, NJ.
Market Capitalization: $7.87M
Prev close: $3.90
Average Daily Volume: 771,277
Days Low: $0.00
Year Low: $1.50
Year High: $12.35
RespireRx Pharmaceuticals Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 02 2020 | RSPI | RespireRx Pharmace ... | Jones Timothy L. | CEO and President | Option Exercise | C | 0.01 | 4,409,063 | 30,863 | 4,409,063 | |
| Oct 02 2020 | RSPI | RespireRx Pharmace ... | Jones Timothy L. | CEO and President | Option Exercise | C | 0.01 | 4,409,063 | 30,863 | 4,409,063 | |
| Oct 02 2020 | RSPI | RespireRx Pharmace ... | Jones Timothy L. | CEO and President | Option Exercise | C | 0.01 | 28 | 0 | 0 | |
| Oct 02 2020 | RSPI | RespireRx Pharmace ... | Jones Timothy L. | CEO and President | Option Exercise | C | 0.01 | 28 | 0 | 0 | |
| Oct 02 2020 | RSPI | RespireRx Pharmace ... | Jones Timothy L. | CEO and President | Option Exercise | J | 0.01 | 28 | 0 | 28 | |
| Oct 02 2020 | RSPI | RespireRx Pharmace ... | Jones Timothy L. | CEO and President | Option Exercise | J | 0.01 | 28 | 0 | 28 | |
| Oct 02 2020 | RSPI | RespireRx Pharmace ... | Jones Timothy L. | CEO and President | Buy | C | 0.00 | 4,409,063 | 0 | 4,409,063 | 0 to 4.4 M |
| Oct 02 2020 | RSPI | RespireRx Pharmace ... | Jones Timothy L. | CEO and President | Buy | C | 0.00 | 4,409,063 | 0 | 4,409,063 | 0 to 4.4 M |
| Oct 02 2020 | RSPI | RespireRx Pharmace ... | MacFarlane Katie | Director | Option Exercise | A | 0.01 | 5,000,000 | 27,000 | 5,000,000 | |
| Oct 02 2020 | RSPI | RespireRx Pharmace ... | MacFarlane Katie | Director | Option Exercise | A | 0.01 | 5,000,000 | 27,000 | 5,000,000 | |
| Oct 02 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman & CS ... | Option Exercise | G | 0.01 | 100 | 1 | 0 | |
| Oct 02 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman & CS ... | Option Exercise | G | 0.01 | 100 | 1 | 0 | |
| Oct 02 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman & CS ... | Option Exercise | G | 0.01 | 100 | 1 | 0 | |
| Oct 02 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman & CS ... | Option Exercise | G | 0.01 | 100 | 1 | 0 | |
| Oct 02 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman & CS ... | Option Exercise | J | 0.01 | 100 | 1 | 100 |
View all RespireRx Pharmaceuticals Inc. insider transactions.